Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ovarian Neoplasms × Docetaxel × Clear all

Status

Sponsor Class

Study Type

Interventional 48 Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 13 Breast Neoplasms 6 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Malnutrition 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nonsquamous Nonsmall Cell Neoplasm of Lung 1 Neurotoxicity Syndromes 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Lung Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 Chemotherapy-induced Peripheral Neuropathy 1 CYP3A Phenotyping 1 Biliary Tract Neoplasms 1

Interventions

Surveys and Questionnaires 19 Blood Specimen Collection 9 Hyperthermic Intraperitoneal Chemotherapy 7 niraparib 6 olaparib 5 Interviews as Topic 5 Cytoreduction Surgical Procedures 5 Carboplatin 5 Amplified Fragment Length Polymorphism Analysis 5 liposomal doxorubicin 4 Psychiatric Rehabilitation 4 Polymerase Chain Reaction 4 Immunohistochemistry 4 Geriatric Assessment 4 Data Collection 4 Bevacizumab 4 1-dodecylpyridoxal 4 Trabectedin 3 Therapeutics 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Magnetic Resonance Spectroscopy 3 Gene Expression Profiling 3 Flow Cytometry 3 Cisplatin 3 CP protocol 3 Biopsy 3 Specimen Handling 2 Paclitaxel 2 Observation 2 Neoadjuvant Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00452985 2012-08-14

OCSTUD

Sanofi

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡